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Abbreviations
NF-kB Nuclear factor kappa-light-chain-enhancer
of activated B cells
NEMO NF-kappa B Essential Modulator
IKBKG Inhibitor of kappa light polypeptide gene
enhancer in B cells, kinase gamma
OL-EDA-ID Osteopetrosis and lymphedema-anhidrotic
ectodermal dysplasia with immunodeficiency
HLH Hemophagocytic Lymphohistiocytosis
IL Interleukin
TLR Toll like receptor
VEGFR-3 Vascular endothelial growth factor receptor-3
RANK Receptor activator of NF-κB
CRP C-Reactive protein
PCR Polymerase chain reaction
HSCT Hematopoietic stem cell transplantation
CADD Combined annotation dependent depletion
TREC T cell receptor excision circle
LPS Lipopolysaccharide
SAC Staphylococcus aureus Cowan I
TNF-α Tumor necrosis factor-α
PMA Phorbol myristate acetate
GVHD Graft versus host disease
To the Editor:
Background
NEMO deficiency syndrome is a rare and heterogeneous con-
dition that presents in early infancy. The phenotypic spectrum
is broad ranging from hypogammaglobulinemia and mild ec-
todermal signs to OL-EDA-ID syndrome, the most severe
phenotype for IKBKG hypomorphic mutations [1].
NF-κB is a transcriptional factor involved in many signaling
pathways, and NEMO plays a key role in its activation. Many
human hypomorphicmutations in IKBKGhave been described
involving IL-1 family protein receptors, TLR, VEGFR-3,
RANK, the ectodysplasin-A receptor, CD40, and TNF receptor
signals. It is known that the regulation of genes essential for cell
adhesion, cell survival, immunoglobulin class switching, oste-
oclast function, and T and B cell development can be impaired
but the knowledge of mechanisms that explain the relationship
between genotype and phenotype is still incomplete.
Case Report
We examined a 3-month-old infant with persistent diarrhea
and failure to thrive. The male patient was born at term to
healthy non-consanguineous Italian parents after an
* Silvia Ricci
slv.ricci@gmail.com
1 Department of Pediatric Immunology, Jeffrey Modell Center for
Primary Immunodeficiencies, University of Florence and Anna
Meyer Children’s University Hospital, viale Pieraccini 24,
50139 Florence, Italy
2 St Giles Laboratory of Human Genetics Infectious Diseases,
Rockefeller Branch, The Rockefeller University, New
York, NY 10065, USA
3 Laboratory of Human Genetics Infectious Diseases, Necker Branch,
INSERM U1163, Imagine Institute, Paris Descartes University,
Paris, France
4 Pediatric Hematology-Immunology Unit, AP-HO, Necker Hospital
for Sick Children, Paris, France
5 Center for the Study of Primary Immunodeficiences, AP-HP, Necker
Hospital for Sick Children, Paris, France
J Clin Immunol (2017) 37:7–11
DOI 10.1007/s10875-016-0350-x
uncomplicated pregnancy. His umbilical separation was de-
layed. At admission, he had a temperature of 38 °C, CRP
concentration of 41 mg/L, white blood cell count of 34.6 ×
103/μl, polymorphonuclear cell count of 14.11 × 103/μl, lym-
phocytic cell count of 15.43 × 103/μl, and hypereosinophilia
(3.8 × 103/μl). Adenovirus was detected in his stool sample.
Physical examination revealed mild dysmorphic features with
frontal bossing, micrognathia, hypoplastic nasal wings, and
flattened alveolar margins. He presented signs of anhidrotic
ectodermal dysplasia with fine and sparse hair, absent eye-
brows, thin translucent skin with dry eczema, and hyperkera-
tosis (Fig. 1(A)). The absence of sweat glands at skin biopsy
confirmed this hypothesis. Radiologic evaluation was per-
formed and the images showed Bbone-in-bone appearance^
of the femoral, iliac, and ischial bones bilaterally, consistent
with a diagnosis of osteopetrosis (Fig. 1(B, B′)). His general
condition rapidly deteriorated with significant dyspnea,
oliguria, and lethargy. He presented acute seizures. A head
CT scan was negative. MRI was not performed. He was im-
mediately admitted to the Pediatric Intensive Care Unit. On
admission, he had leukocytosis (52.24 × 103/μl) and the signs
of secondary hemophagocytic lymphohistiocytosis with
prolonged fever, hepatosplenomegaly, anemia (Hb 6.9 g/dl),
elevated ferritinemia (37,300 ng/ml), LDH (2105 U/L), low
fibrinogen (93 mg/dl), and hypertriglyceridemia (700 mg/dl).
Conventional respiratory and circulatory support with
inotropes was necessary. A thoracic scan image was concor-
dant with interstitial pneumonitis. Pneumocystis jirovecii and
CMV DNAwere identified in the bronchoalveolar lavage by
PCR. The patient was successfully treated with meropenem,
trimethoprim/sulfamethoxazole, and ganciclovir. The signs of
concomitant macrophage activation syndrome were gradually
normalized under systemic corticosteroid therapy. During his
prolonged hospitalization, the patient also displayed a tran-
sient and inconstant lymphedema of the lower limbs.
Immunological assay was performed at 4 months of life. The
patient presented severe hypogammaglobulinemia with IgG
(1.73 g/L with normal range 2.22–8.46 g/L), IgA (0.01 g/L
with normal range 0.06–0.6 g/L), and IgM (0.04 g/L with
normal range 0.28–0.39 g/L). TRECs and KRECs were nor-
mal. Flow cytometry immunophenotyping revealed low NK
and B memory cell counts (Table 1). NK cell functional
Fig. 1 Right lower extremity with signs of ectodermal dysplasia (A).
Radiological findings of osteopetrosis with increased bone intensity,
bone-within-bone appearance of the iliac and ischial bones (B), and of
femoral epiphyses (B′). Functional test evaluation performed by ELISA:
impaired IL-6 production in patient after 48 h of activation of whole blood
with IL-1β, LPS, and S aureus Cowan I (SAC) (C) and impaired IL-10
production after 48 h of activation with TNF-α. Increased IL-6 and IL-10
production after PMA/Ionomycin stimulation (C′). The results (C and C′)
are representative of two tests
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activity (CD107a expression) could not be determined due to
the low number of NK cells. Proliferative T cell responses to
mitogenic stimuli were normal (Table 1). We performed an
analysis of the IKBKG sequence (NM_001099856.3) from
both genomic DNA and cDNA and we identified a novel
missense mutation c.1238A>G (p.H413R) within exon 10
on the zinc finger domain. The substituted histidine is highly
conserved among different species (Fig. 2). Using a bioinfor-
matic system (Polyphen and SIFT-Sort Intolerant From
Tolerant), the new mutation is predicted to be damaging with
a score of 0.99 (sensitivity 0.09; specificity 0.99) and to affect
protein function with a score of 0.00 (intolerant), respectively.
The CADD score was also elevated (22.9). We performed a
careful dermatological examination of the patient’s mother,
we did not observe any of the nail, hair, dental, or skin find-
ings typical of incontinentia pigmenti. Moreover, there was no
history of dermatological problems in the family. Maternal
sequencing on genomic and cDNA revealed the WT
IKBKG on both alleles. We evaluated the patient’s blood
cells after activation with TNF-α, IL-1β, and other agonists
of TLRs. The response of the patient’s blood cells to IL-
1β, LPS (agonist of TLR-4), and SAC was abnormal, in
terms of IL-6 production (Fig. 1(C)). Moreover, the re-
sponse to TNF-α was impaired in terms of IL-10 produc-
tion (Fig. 1(C′)). IL-6 and IL-10 production was measured
Table 1 Patient’s lymphocyte phenotyping and T-lymphocytes
proliferation in response to mitogens, performed by FACS at
5 months of life
Cell population % Cells/μl
Lymphocytes 7945
T-Lymphocytes 75 7282
CD3+CD4+ 66 6369
CD3+CD8+ 9 881
CD45+CD3+CD4+CD31+ 24 1528
CD45+CD3+CD4+CD45RO+ 54 3439
CD45+CD3+CD4+CD45RA+ 46 2930
CD45+CD3+CD4+CD45RA+CD31+ 39 2485
B-Lymphocytes 5 481
CD27+ 2 10
CD27+IgM+IgD+ 76 9
CD27+IgM−IgD− 24 2
CD3−CD16+CD56+ 2 206
CD3−CD19+CD40+ 99 1906
CD3+CD8−CD40L 97 6175
T-lymphocytes proliferation assay
CFSE+ w/o stimulus 98%
PHA (10 μM) 77%
Anti-CD3 antibody and IL-2 (30 U/ml) 85%
Fig. 2 The NEMO gene structure and its zinc finger (ZF) which extends
from amino acid residues 397 to 419. The three cysteine residues and the
single histidine (H413) residue that coordinate a zinc ion are indicated.
H413 is high conserved among different species (modified by Shifera AS
The zinc finger domain of IKKγ (NEMO) protein in health and disease J.
Cell. Mol. Med.)
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by enzyme-linked immunosorbent assay (ELISA) after 48 h
of ac t iva t ion . For pers i s ten t b loody dia r rhea ,
hypoproteinemia and feeding intolerance parenteral nutri-
tion was necessary. Colon biopsy showed macroscopic
signs of enterocolitis with diffuse eosinophilic infiltrates in
the lamina propria of the colon. Despite IV antimicrobial
prophylaxis and regular infusions of IV immunoglobulin, at
10 months of age, the patient was readmitted presenting a
new episode of catheter-associated bacteremia from E. coli.
At 13 months of age, the patient underwent a
myeloablative conditioning regimen consisting of thiotepa,
treosulfan, and fludarabine followed by haploidentical stem
cell transplantation with TCR-alpha/beta and CD19 deple-
tion. He received anti-thymocyte globulin and mycopheno-
late mofetil with a complete antimicrobial prophylaxis as a
prevention of acute GVHD and infectious complications.
He died unexpectedly from acute respiratory distress and
sepsis due to multiresistant Pseudomonas aeruginosa 6 days
post HSCT.
Discussion and Conclusion
We report a case characterized by a severe clinical presen-
tation and fatal outcome associated with a genotype never
previously described. The clinical features of the case, in
particular the EDA signs and the life-threatening infection,
led us to consider a diagnosis of a severe form of NEMO
deficiency syndrome. Indeed, the association of
osteopetrosis/lymphedema and EDA-ID is indicative of
the most severe phenotype. The immunological assay
was completely compatible with previously reported cases.
As previously described, the CD40-CD40L signaling on
the dendritic cells and B cells involves NEMO in
NF-κB activation. Impaired CD40 signaling in pulmonary
dendritic cells may result in a major susceptibility to fungi
infections similar to patients with hyper IgM syndrome
[2]. Moreover, the patient displayed a very low NK cell
count which can explain his increased susceptibility to the
herpes virus group, including CMV [3]. The use of HSCT
in NEMO deficiency syndrome remains controversial and
few data are available concerning the transplantation of a
patient with a novel NEMO mutation [5]. Despite the
known intrinsic difficulties with engraftment for these pa-
tients, having evaluated the severity of his life-threatening
infections and their sequelae, we decided that HSCT was
the only therapeutic option. A similar case of OL-EDA-ID
syndrome caused by the substitution of a stop codon with
a tryptophan (X420W) on the zinc finger region in the
NEMO gene has been reported. This substitution changes
the length of the final protein, resulting 27 amino acids
longer than the WT protein [2]. Here, we describe a
completely different genotype, a novel missense mutation,
which substitutes histidine for arginine at amino acid 413
on the zinc finger domain, and which resulted in an equal-
ly severe phenotype. In addition, this case is characterized
by the precocious and serious development of intestinal
failure and hemophagocytic lymphohistiocytosis. These
clinical signs have previously been described but never
together in association with a severe OL-EDA-ID pheno-
type. Recently, a variation involving the same amino ac-
id—p.H413Y—causing IP syndrome in a female patient
with a random X-inactivation has been reported [4]. In
2008, Cordier et al. presented a complete analysis of the
structural and functional properties of the ZF motif of
NEMO. The integrity of the tetrahedral zinc coordination
site formed by H413 and another three cysteine residues
determines the ββα scaffold of NEMO ZF (Fig. 2). In
our case, the highly conserved H413 is substituted by an
arginine; this implies an impaired stability of the ZF fold
which may alter its protein recognition abilities. It appears
that the disruption of C-terminus of NEMO gene, caused
by nonsense mutation or by a missense mutation of a key
conjugating residue, lead to similar severe phenotype.
Moreover, functional complementation assays using the
patient’s mononuclear cells showed that the H413R
NEMO mutation leads to a strong defect of LPS, IL-1β,
and TNF-α-induced NF-κB activation, as compared to
WT NEMO (Fig. 1(C, C′)). Interestingly, cytokine produc-
tion is higher in patient than in control after PMA/
ionomycin stimulation. Zilberman-Rudenko et al. have re-
cently described a distinct group of patient with inflamma-
tory symptoms caused by gain-of-function C-terminus de-
letion which confers increased responsiveness to innate
immune stimuli. Regulated activation of NF-kB transcrip-
tion factors family is important in immune cell function
and inflammatory responses. Our case represents an exam-
ple of immunodysregulation characterized for clinical and
molecular features of immunodeficiency and auto-inflam-
mation. We are aware that more studies are necessary to
establish all pathogenetic mechanisms of this point muta-
tion; unfortunately, we did not obtain the family’s consent
for a second skin biopsy or for other investigations. In
conclusion, we report a novel missense mutation responsi-
ble for one of the most complex and severe clinical pre-
sentations of reported NEMO deficiency cases. It appears
that the disruption of C-terminus of NEMO gene,
caused by nonsense mutation or by a missense mutation
of a key conjugating residue, lead to similar severe
phenotype. We recommend that each novel variation is
described and submitted to public databases because any
additional data will provide insight into genotype-
phenotype correlation and will improve patient care for
infants with NEMO deficiency syndrome.
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